CDEK
← All organizations

Rhythm Pharmaceuticals, Inc.

For profitContributed to NMEWebsite ↗

Also known as: RHYTHM | Rhythm Pharmaceuticals, Inc. | RHYTHM PHARMACEUTICALS INC | Rhythm Pharmceuticals, Inc | Rhythm Pharmceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jan 1, 2012

First marketed drug

Nov 25, 2020

First NDA

Nov 25, 2020

Last known activity

Nov 10, 2025

Timeline

2000s

  1. Jun 1, 2008

    Rhythm Pharmaceuticals, Inc.— Founded

2020s

  1. Nov 25, 2020

    setmelanotide— Marketing Organization

  2. Nov 25, 2020

    setmelanotide— NDA Organization

  3. Nov 25, 2020

    setmelanotide— NDA Secondary Org

Drugs by trial phase (5 distinct, 27 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (49)

Details

Founded
Boston, MA, US Jun 1, 2008
First NDA
Nov 25, 2020
Last known activity
Nov 10, 2025

Designations held

  • Orphan drug
  • Priority review
  • Breakthrough therapy